Biblio Discovery — Demo Discovery Service

8 hasil untuk "Mathieu Meunier"

Menampilkan 1–8 · 0,18 detik · RSS

  1. Artikel Jurnal

    Lower‐risk myelodysplastic syndromes: Current treatment options for anemia

    Mathieu Meunier; Sophie Park

    eJHaem, Vol. 3 No. 4 · 2022 · Inggris · DOAJ

    Abstract Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematological disorders. Treatment options are classified and defined by prognostic risk based on the International Prognostic Scoring System (IPSS) and, more recently, the revised IPSS (IPSS‐R). The treatment goal for…

  2. Artikel Jurnal Teks lengkap

    Extracellular Vesicles and MicroRNA in Myelodysplastic Syndromes

    Mathieu Meunier; David Laurin; Sophie Park

    Cells, Vol. 12 No. 4 · 2023 · Inggris · DOAJ Scopus

    The bone marrow niche plays an increasing role in the pathophysiogenesis of myelodysplastic syndromes. More specifically, mesenchymal stromal cells, which can secrete extracellular vesicles and their miRNA contents, modulate the fate of hematopoietic stem cells leading to leukemogenesis…

  3. Artikel Jurnal Teks lengkap

    Cytomegalovirus detection is associated with ICU admission in non-AIDS and AIDS patients with Pneumocystis jirovecii pneumonia

    Alexandre Perret; Marion Le Marechal; Raphaele Germi dkk.

    PLOS ONE, Vol. 19 No. 1 · 2024 · Inggris · PLOS Scopus

    Objectives: Cytomegalovirus (CMV) is frequently detected in lung and/or blood samples of patients with Pneumocystis jirovecii pneumonia (PJP), although this co-detection is not precisely understood. We aimed to determine whether PJP was more severe in case of CMV detection. Methods: We…

    Juga tersedia di: DOAJ

  4. Artikel Jurnal

    Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study

    Sophie Park; José Labarère; Raymond Merle dkk.

    BMJ Open, Vol. 12 No. 10 · 2022 · Inggris · DOAJ Scopus

    Introduction Suspicion of myelodysplastic syndromes (MDS) is the most common reason for bone marrow aspirate in elderly patients. Peripheral blood neutrophil myeloperoxidase expression quantified by flow cytometric analysis might rule out MDS for up to 35% of patients referred for suspected…

  5. Artikel Jurnal

    Flow cytometric lyophilised reagent tube assay for peripheral blood neutrophil myeloperoxidase expression to rule out myelodysplastic neoplasms at a university hospital: a diagnostic accuracy study

    Sophie Park; José Labarère; Arnaud Seigneurin dkk.

    BMJ Open, Vol. 15 No. 8 · 2025 · Inggris · DOAJ Scopus

    Objectives Although flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression can accurately rule out myelodysplastic neoplasms (MDS), it lacks reliability and efficiency due to the practical limitations of laboratory-developed liquid reagent-based assays. This study aimed…

  6. Artikel Jurnal

    Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes

    Sophie Park; Olivier Kosmider; Frédéric Maloisel dkk.

    Haematologica, Vol. 104 No. 3 · 2019 · Inggris · DOAJ Scopus

    Erythropoiesis-stimulating agents are generally the first line of treatment of anemia in patients with lower-risk myelodysplastic syndrome. We prospectively investigated the predictive value of somatic mutations, and biomarkers of ineffective erythropoiesis including the flow cytometry RED score…